Cours CV Sciences, Inc. Other OTC
Actions
CVSI
US1266541028
Produits pharmaceutiques
CA 2022 | 16,2 M 14,66 M | CA 2023 | 16 M 14,48 M | Capitalisation | 5,47 M 4,94 M |
---|---|---|---|---|---|
Résultat net 2022 | -9 M -8,14 M | Résultat net 2023 | 3 M 2,71 M | VE / CA 2022 | 0,36 x |
Dette nette 2022 | 917 k 830 k | Trésorerie nette 2023 | 875 k 792 k | VE / CA 2023 | 0,29 x |
PER 2022 |
-0,44
x | PER 2023 |
1,77
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99,98% |
Dernier transcript sur CV Sciences, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/06/14 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 26/12/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/06/14 |
Jamie Corroon
BRD | Director/Board Member | 54 | 21/07/22 |
William McCorkle
BRD | Director/Board Member | 56 | 21/10/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,08% | 662 Md | |
+21,85% | 546 Md | |
-4,77% | 359 Md | |
+16,97% | 323 Md | |
+5,69% | 290 Md | |
+13,68% | 234 Md | |
+3,65% | 198 Md | |
-11,12% | 194 Md | |
-3,40% | 157 Md |